Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies

Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies

Stanley Schwartz1, Benjamin A Kohl21Department of Endocrinology, Diabetes, and Metabolism, University of Pennsylvania, Philadelphia, Pennsylvania, USA; 2Department of Anesthesiology and Critical Care, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USAAbstract: The rates...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Stanley Schwartz, Benjamin A Kohl
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2010
Materias:
Specialties of internal medicine
RC581-951
Acceso en línea:https://doaj.org/article/d23891c3616d47fcbaad20237dd3bb80
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares